J. Camps

182 DETERMINATION OF PARAOXONASE-3 CONCENTRATION IN HUMAN SERUM: METHOD EVALUATION, REFERENCE VALUES AND INFLUENCE OF GENOTYPES IN A POPULATION-BASED STUDY

415 MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND PARAOXONASE-1 IN PERIPHERAL ARTERIAL DISEASE: A MODEL OF INTERACTION BETWEEN DEFENSE AGAINST OXIDATIVE STRESS AND INFLAMMATION

629 ANTIRETROVIRAL TREATMENT-INDUCED DYSLIPIDEMIA IN HIV-INFECTED PATIENTS IS INFLUENCED BY THE APOC3-RELATED RS10892151 POLYMORPHISM

407 DUFFY BLOOD ALLOANTIGEN SYSTEM INFLUENCES INFLAMMATORY CHEMOKINE CONCENTRATION IN SERUM BUT NOT PLASMA: GEOGRAPHIC DIFFERENTIATION AS AN ADDITIONAL CONFOUNDING FACTOR

P334 HIV INFECTION INDUCES MAJOR CHANGES IN HDL PARTICLE SIZE DISTRIBUTION AND COMPOSITION: THE EFFECT OF ANTIRETROVIRAL TREATMENT AND DISEASE SEVERITY

MS131 THE EXPRESSION OF CYTOKINE GENES IN THE AORTA INFLUENCED BY DIET: THE EFFECT OF MCP-1 DEFICIENCY

MCP-1 DEFICIENCY PREVENTS HIGH-FAT-INDUCED OBESITY AND MODIFIES LIPID AND GLUCOSE METABOLISM IN HYPERLIPIDEMIC MICE

EVALUATION OF HIGH DENSITY LIPOPROTEIN-CHOLESTEROL MEASUREMENT IN A CHRONICALLY HIV-INFECTED POPULATION

RELATIONSHIP BETWEEN PARAOXONASE-1 (PON1), MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND SUB-CLINICAL ATHEROSCLEROSIS IN HIV-1 INFECTED PATIENTS

IMMUNOHISTOCHEMICAL ANALYSIS OF PARAOXONASES-1, 2, AND 3 IN HUMAN ATHEROMA PLAQUES